Pages that link to "Q73243846"
Jump to navigation
Jump to search
The following pages link to Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus (Q73243846):
Displaying 50 items.
- Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants (Q24188100) (← links)
- Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants (Q24197958) (← links)
- Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants (Q24235550) (← links)
- Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants (Q24235778) (← links)
- Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants (Q24242285) (← links)
- Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants (Q24242605) (← links)
- Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants (Q24244935) (← links)
- Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants (Q24245833) (← links)
- Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants (Q24248666) (← links)
- Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit (Q24604121) (← links)
- Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practice (Q24631088) (← links)
- Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus (Q26766965) (← links)
- The role of the intestinal microcirculation in necrotizing enterocolitis (Q27691434) (← links)
- Guidelines for feeding very low birth weight infants (Q28083396) (← links)
- Nonsteroidal anti-inflammatory agents in neonates (Q28196259) (← links)
- Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus (Q30411583) (← links)
- Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts. (Q33947204) (← links)
- Comparative tolerability of pharmacological treatments for patent ductus arteriosus (Q34303482) (← links)
- Risk factors of mild rectal bleeding in very low birth weight infants: a case control study (Q34449100) (← links)
- Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration (Q34517223) (← links)
- Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants (Q35540152) (← links)
- Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant (Q35571728) (← links)
- Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns? (Q35580251) (← links)
- Patent ductus arteriosus in premature neonates (Q35607990) (← links)
- Lung function in very preterm infants with patent ductus arteriosus under conservative management: an observational study (Q35819433) (← links)
- Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? (Q35834962) (← links)
- A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus (Q36045482) (← links)
- Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure (Q36214850) (← links)
- Patent ductus arteriosus: an overview (Q36290879) (← links)
- Clinical experience with intravenous Ibuprofen lysine in the pharmacologic closure of patent ductus arteriosus (Q36290884) (← links)
- Pharmacoeconomics of Surgical Interventions vs. Cyclooxygenase Inhibitors for the Treatment of Patent Ductus Arteriosus (Q36290893) (← links)
- Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus (Q36327648) (← links)
- Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants (Q37072171) (← links)
- Conservative treatment for patent ductus arteriosus in the preterm (Q37174836) (← links)
- Cyclooxygenase (COX) Inhibitors and the Newborn Kidney (Q37277333) (← links)
- Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals (Q37324451) (← links)
- Patent ductus arteriosus in preterm infants: do we have the right answers? (Q37451050) (← links)
- Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? (Q37698200) (← links)
- Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants (Q37824909) (← links)
- Current evidence on the safety profile of NSAIDs for the treatment of PDA (Q37900320) (← links)
- Improved Closure of Patent Ductus Arteriosus With High Doses of Ibuprofen (Q37981592) (← links)
- Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosus (Q38380099) (← links)
- Ibuprofen Versus Indomethacin for Medical Closure of the Patent Arterial Duct: A Pooled Analysis by Route of Administration (Q38548285) (← links)
- Pharmacologic, pharmacodynamic, and pharmacokinetic considerations with intravenous Ibuprofen lysine (Q40199090) (← links)
- The Methodology of Doppler-Derived Central Blood Flow Measurements in Newborn Infants (Q40626741) (← links)
- A Potential Biomarker for Acute Kidney Injury in Preterm Infants from Metabolic Profiling (Q42228034) (← links)
- Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants (Q42534997) (← links)
- Echocardiography predicts closure of patent ductus arteriosus in response to ibuprofen in infants less than 28week gestational age (Q42955574) (← links)
- Ibuprofen in very preterm infants impairs renal function for the first month of life. (Q43245134) (← links)
- Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus (Q44458227) (← links)